Precision Biosciences (DTIL) Interest Expenses (2018 - 2026)

Precision Biosciences' (DTIL) quarterly Interest Expenses came in at $499000.0 in Q1 2026, up 3.1% year-on-year from $484000.0 in Q1 2025, and down 43.81% on a QoQ basis from $888000.0 in Q4 2025.

Precision Biosciences (DTIL) Interest Expenses (2018 - 2026) Analysis & Trends

Precision Biosciences (DTIL) has 9 years of Interest Expenses data on file, last reported at $499000.0 in Q1 2026.

  • On a quarterly basis, Interest Expenses rose 3.1% year-over-year to $499000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 3.22% increase from a year earlier, with the FY2025 full-year figure at $145.3 million, up 6.14% from the prior year.
  • Interest Expenses for Q1 2026 stood at $499000.0, down from $888000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for DTIL reached as high as $10.4 million in Q2 2024 and fell as low as $297000.0 in Q3 2023.
  • Historically, Interest Expenses has averaged $3.3 million across 5 years, with a median of $888000.0 in 2025.
  • Across the five-year window, Interest Expenses sank 95.02% in 2022 and surged 3250.84% in 2024, its largest moves.
  • Year by year, Interest Expenses stood at $1.8 million in 2022, then slumped by 59.88% to $739000.0 in 2023, then slumped by 32.61% to $498000.0 in 2024, then surged by 78.31% to $888000.0 in 2025, then plunged by 43.81% to $499000.0 in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $499000.0 in Q1 2026, $888000.0 in Q4 2025, and $8.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - -42,141.15
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 100,000.00
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn 69.29 Mn
10 Precision Biosciences 184.64 Mn 156.34 Mn - 499,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 499,000.00
Mar 31, 2026 499,000.00
Dec 31, 2025 888,000.00
Dec 31, 2025 888,000.00
Sep 30, 2025 8.01 Mn
Sep 30, 2025 8.01 Mn
Jun 30, 2025 1.41 Mn
Jun 30, 2025 1.41 Mn
Mar 31, 2025 484,000.00
Mar 31, 2025 484,000.00
Dec 31, 2024 498,000.00
Dec 31, 2024 498,000.00
Sep 30, 2024 9.95 Mn
Sep 30, 2024 9.95 Mn
Jun 30, 2024 10.42 Mn
Jun 30, 2024 10.42 Mn
Mar 31, 2024 574,000.00
Mar 31, 2024 574,000.00
Dec 31, 2023 739,000.00
Dec 31, 2023 739,000.00